O'Shaughnessy Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

O'Shaughnessy Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.07M	Buy	191,537 +5,772	+3%	+$95.5K	0.01%	723
2026 Q1	$3.44M	Buy	185,765 +48,509	+35%	+$851K	0.02%	652
2025 Q4	$2.14M	Sell	137,256 -33,980	-20%	-$486K	0.01%	811
2025 Q3	$2.51M	Buy	171,236 +39,514	+30%	+$587K	0.01%	728
2025 Q2	$2.04M	Buy	131,722 +975	+0.7%	+$14.4K	0.01%	765
2025 Q1	$1.94M	Buy	130,747 +41,192	+46%	+$577K	0.02%	699
2024 Q4	$1.19M	Sell	89,555 -14,628	-14%	-$201K	0.01%	882
2024 Q3	$1.49M	Buy	104,183 +41,875	+67%	+$594K	0.01%	752
2024 Q2	$806K	Sell	62,308 -26,355	-30%	-$349K	0.01%	929
2024 Q1	$1.23M	Buy	88,663 +26,735	+43%	+$389K	0.01%	744
2023 Q4	$884K	Sell	61,928 -20,561	-25%	-$292K	0.01%	799
2023 Q3	$1.28M	Buy	82,489 +8,671	+12%	+$134K	0.02%	607
2023 Q2	$1.16M	Buy	73,818 +4,729	+7%	+$77.5K	0.02%	602
2023 Q1	$1.14M	Sell	69,089 -64,930	-48%	-$1.03M	0.02%	607
2022 Q4	$2.09M	Sell	134,019 -20,364	-13%	-$284K	0.03%	421
2022 Q3	$2M	Sell	154,383 -7,214	-4%	-$100K	0.04%	392
2022 Q2	$2.27M	Sell	161,597 -33,561	-17%	-$479K	0.04%	356
2022 Q1	$2.79M	Buy	195,158 +94,217	+93%	+$1.38M	0.05%	330
2021 Q4	$1.38M	Sell	100,941 -9,787	-9%	-$137K	0.02%	438
2021 Q3	$1.81M	Buy	110,728 +57,621	+108%	+$967K	0.04%	332
2021 Q2	$894K	Buy	53,107 +20,184	+61%	+$344K	0.02%	499
2021 Q1	$601K	Buy	32,923 +9,852	+43%	+$177K	0.01%	544
2020 Q4	$420K	Sell	23,071 -846	-4%	-$14.8K	0.01%	571
2020 Q3	$427K	Buy	23,917 +1,705	+8%	+$31K	0.01%	481
2020 Q2	$398K	Buy	22,212 +18,067	+436%	+$324K	0.01%	456
2020 Q1	$63K	Sell	4,145 -2,235	-35%	-$40.5K	﹤0.01%	730
2019 Q4	$126K	Buy	6,380 +6,372	+79,650%	+$122K	﹤0.01%	733
2019 Q3	$0	Buy	+8	New	+$138	﹤0.01%	1232

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

O'Shaughnessy Asset Management's TAK Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Takeda Pharmaceutical (TAK) stake by 3.1% in Q2 2026, buying an estimated $95.5K and bringing the position to 191,537 shares worth $3.07M. The position accounts for 0.01% of the portfolio, ranked #723.

O'Shaughnessy Asset Management first reported a position in TAK in Q3 2019 and has held it in 28 quarters since. The position peaked at $3.44M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

O'Shaughnessy Asset Management held 191,537 shares of Takeda Pharmaceutical worth $3.07M as of Q2 2026.
O'Shaughnessy Asset Management bought 5,772 Takeda Pharmaceutical shares in Q2 2026, an estimated $95.5K.
Takeda Pharmaceutical made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #723 holding.
O'Shaughnessy Asset Management first reported a position in Takeda Pharmaceutical in Q3 2019 and has held it in 28 quarters since.
O'Shaughnessy Asset Management's Takeda Pharmaceutical position peaked at $3.44M in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.